T2 BIOSYSTEMS INC's ticker is and the CUSIP is 89853L203. A total of 35 filers reported holding T2 BIOSYSTEMS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $599,196 | – | 1,302,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 749,599 | $344,816 | 0.30% |
| CVI Holdings, LLC | 549,542 | $252,789 | 0.10% |
| Anson Funds Management LP | 1,050,076 | $483,034 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 86,909 | $40 | 0.00% |
| Walleye Capital LLC | 390,978 | $179,850 | 0.00% |
| Hudson Bay Capital Management LP | 1,302,600 | $599,196 | 0.00% |
| Warberg Asset Management LLC | 25,955 | $11,939 | 0.00% |
| Capital Advisors, Ltd. LLC | 1,439 | $1 | 0.00% |
| UBS Group AG | 40 | $18 | 0.00% |
| WealthPLAN Partners, LLC | 506 | $233 | 0.00% |